1-4 of 4
Yijiang Shi, MD PhD
Close
Sort by
Journal Articles

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Mario I Vega, PhD, Yijiang Shi, MD PhD, Patrick Frost, PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1821.
https://doi.org/10.1182/blood-2019-121480
Published: 2019
Journal Articles

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

Mario Vega, PhD, Patrick Frost, PhD, Carolyne Bardeleben, PhD, Yijiang Shi, MD PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3833.
https://doi.org/10.1182/blood.V130.Suppl_1.3833.3833
Published: 2017
Journal Articles

AKT Kinase Addiction in Multiple Myeloma.

Carolyne Bardeleben, PhD, Huajun Yan, PhD, Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, PhD, Sanjai Sharma, MD, Alan Lichtenstein, MD
Journal: Blood
Blood (2006) 108 (11): 3431.
https://doi.org/10.1182/blood.V108.11.3431.3431
Published: 2006
Journal Articles

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Huajun Yan, PhD, Patrick Frost, PhD, Yijiang Shi, MD & PhD, Bao Hoang, PhD, Sanjai Sharma, MD, Myrna Fisher, Joseph Gera, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2005) 106 (11): 1582.
https://doi.org/10.1182/blood.V106.11.1582.1582
Published: 2005